| Cancer | TCGA SampleId | FusionPair | E-value | Tier | Frame | 5'Gene Junction | 3'Gene Junction | Details | CNV | Somatic Muts | WGS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OV | TCGA.30.1718.01A | GATAD2B::NUP210L | 0.45 | tier1 | 5UTR-CDS | Chr1:153895209/-1 | Chr1:153965565/-1 |  |
GATAD2B NUP210L | GATAD2B NUP210L | NA |
| LUAD | TCGA.44.7660.01A | GATAD2B::NUP210L | 0.45 | tier1 | 5UTR-CDS | Chr1:153895209/-1 | Chr1:153982597/-1 | |
GATAD2B NUP210L | GATAD2B NUP210L | NA |
| BRCA | TCGA.B6.A0I1.01A | GATAD2B::NUP210L | 0.45 | tier1 | 5UTR-CDS | Chr1:153895209/-1 | Chr1:153967656/-1 | |
GATAD2B NUP210L | GATAD2B NUP210L | non-validated |
| UCS | TCGA.N5.A59F.01A | GATAD2B::NUP210L | 0.45 | tier1 | 5UTR-CDS | Chr1:153895209/-1 | Chr1:154076686/-1 | |
GATAD2B NUP210L | GATAD2B NUP210L | NA |